Stories by Naim Alkhouri

Naim Alkhouri, M.D., currently serves as a Staff Physician with Cleveland Clinic's Children's Hospital and Digestive Disease Institute. Dr. Alkhouri is board certified in internal medicine and pediatrics. He completed his medical degree at the University of Damascus, Damascus, Syria. His post-graduate training includes a general surgery rotation at the American University of Beirut, Beirut, Labanon; an OB/GYN rotation at McGill University in Montreal, Canada; a one-year internal medicine and pediatric internship followed by a three-year internal medicine and pediatric residency at Albert Einstein Medical Center in Philadelphia; a three-year pediatric gastroenterology, hepatology and nutrition fellowship at Cleveland Clinic; and finally, a Transplant Hepatology fellowship at the Digestive Disease Institute, Cleveland Clinic. Dr. Alkhouri is a member of several professional organizations, including the American Association for the Study of Liver Disease; American Gastroenterology Association; American College of Gastroenterology; and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Among many research awards over the years, Dr. Alkhouri recently received the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Fellow Research Award for his prospective evaluation of the pediatric NAFLD fibrosis index and ELF markers in children with fatty liver disease. He also received the 2010 Pediatric Fellow Research Day Award for Best Overall Study for his "New Animal Model of Steatohepatitis that Captures both Pathophysiology and Metabolic Context of Human Steatohepatitis." Dr. Alkhouri is an established clinical and basic researcher and has published multiple research articles in peer-reviewed journals, textbook chapters, as well as having contributed abstracts and presentations at a number of professional association meetings. Dr. Alkhouri's specialty interests include nonalcoholic fatty liver disease, viral hepatitis, autoimmune liver disease, end stage liver disease, liver transplantation, and inflammatory bowel disease.